Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Real-World Study of Ceftazidime Avibactam in China

View source ↗

Summary

Real-world study of ceftazidime-avibactam in China was terminated, with results posted, evaluating its use for hospital-acquired pneumonia, ventilator-associate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Hospital Acquired Pneumonia, Ventilator Acquired Pneumonia | Status: TERMINATED | Results posted: 2025-09-04